Athena Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Sell
4,605
-1,874
-29% -$167K 0.28% 82
2026
Q1
$465K Hold
6,479
0.24% 97
2025
Q4
$514K Sell
6,479
-10
-0.2% -$788 0.26% 90
2025
Q3
$489K Hold
6,489
0.25% 92
2025
Q2
$448K Hold
6,489
0.25% 94
2025
Q1
$440K Buy
6,489
+296
+5% +$17.7K 0.27% 87
2024
Q4
$278K Sell
6,193
-428
-6% -$24K 0.16% 120
2024
Q3
$416K Hold
6,621
0.24% 99
2024
Q2
$391K Buy
6,621
+78
+1% +$4.88K 0.24% 99
2024
Q1
$522K Buy
6,543
+156
+2% +$11.9K 0.31% 78
2023
Q4
$504K Sell
6,387
-156
-2% -$11.1K 0.33% 73
2023
Q3
$457K Hold
6,543
0.33% 70
2023
Q2
$452K Hold
6,543
0.31% 73
2023
Q1
$486K Sell
6,543
-10
-0.2% -$839 0.35% 68
2022
Q4
$611K Buy
6,553
+112
+2% +$10.8K 0.45% 53
2022
Q3
$614K Sell
6,441
-132
-2% -$13.1K 0.52% 47
2022
Q2
$609K Sell
6,573
-17
-0.3% -$1.66K 0.48% 48
2022
Q1
$670K Buy
+6,590
New +$692K 0.52% 47

Other funds holding CVS

Athena Investment Management's CVS Position: Q2 2026 in Review

Athena Investment Management reduced its CVS Health (CVS) stake by 29% in Q2 2026, selling an estimated $167K and leaving 4,605 shares worth $476K. The position accounts for 0.28% of the portfolio, ranked #82.

Athena Investment Management first reported a position in CVS in Q1 2022 and has held it in 18 quarters since. The position peaked at $670K in Q1 2022. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Athena Investment Management held 4,605 shares of CVS Health worth $476K as of Q2 2026.
  • Athena Investment Management sold 1,874 CVS Health shares in Q2 2026, an estimated $167K.
  • CVS Health made up 0.28% of Athena Investment Management's portfolio in Q2 2026, its #82 holding.
  • Athena Investment Management first reported a position in CVS Health in Q1 2022 and has held it in 18 quarters since.
  • Athena Investment Management's CVS Health position peaked at $670K in Q1 2022.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Athena Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.